000 01467cas a2200361 c 4500
999 _c341899
_d341899
_x1
001 341899
003 ES-MaUEC
005 20230102115955.0
006 s||||oo ||| 0 0
007 cr c| ||||||||
008 190206c20139999gw || poo 0 0eng d 
022 _a2515-1363
022 _a2515-1355
040 _aNLE
_beng
_erda
_epn
_cNLE
_dCOO
_dUX1
_dOH1
_dOCLCO
_dNLM
_dOCLCO
_dOCLCF
_dAU@
_dUKMGB
_dOCLCA
_dDLC
_dES-MaUEC
050 0 4 _aRM281
_bES
210 1 0 _aTher Adv Vaccines Immunother 2 dnlm
222 0 _aTherapeutic advances in vaccines and immunotherapy
245 0 0 _aTherapeutic Advances in Vaccines and Immunotherapy
264 1 _aCalifornia
_bSage Publications
_c2009-
300 _a1 recurso en línea
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
362 1 _aBegan with Volume 5, Issue 6 (December 2017).
988 _aSAGE Premier
650 7 _2embne
_aVacunas
_vPublicaciones periódicas
_9140409
776 0 8 _iAlso issued in print as:
_tTherapeutic advances in vaccines and immunotherapy
_x2515-1355
780 0 0 _tTherapeutic advances in vaccines
_x2051-0144
_w(DLC) 2014243262
_w(OCoLC)865187130
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://journals.sagepub.com/loi/TAV
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
866 0 _a2013-
942 _2lcc
_cRE
_n0
998 _b10/2021
_dr
_eh
_zSI